Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Arthur Allen
Stay informed with Arthur Allen’s coverage and analysis for Fortune.
Health
With RFK Jr. in charge, supplement makers see chance to cash in
By
KFF Health News
and
Arthur Allen
Health
As COVID ‘contrarians’ take power, experts warn we’re even less prepared for the next pandemic
By
Arthur Allen
and
KFF Health News
Health
How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices
By
Arthur Allen
and
KFF Health News
Aging Well
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
By
Arthur Allen
and
KFF Health News
Finance
Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
By
Arthur Allen
and
KFF Health News
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By
Arthur Allen
and
KFF Health News
Health
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
By
Arthur Allen
and
Kaiser Health News
Health
Inside the lobbying push to get Medicare to pay for a controversial Alzheimer’s drug
By
Arthur Allen
and
Kaiser Health News
Health
With billions spent and ‘wartime’ declared, why are vaccines still in short supply?
By
Rachana Pradhan
,
Arthur Allen
, and others